Recruiting
Digital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive Symptoms（CADS-D )
CADS-D aimes to evaluate the effectiveness and feasibility of a newly DCBT program for Chinese adolescents with depressive symptoms.
ClinicalTrials.gov IDNCT07163013
PhaseNA
Enrollment200
SponsorFirst Affiliated Hospital of Chongqing Medical University
Age12 Years – 18 Years
SexALL
Conditions studied
Depressive Symptom
About this study
CADS-D aimes to evaluate the effectiveness and feasibility of a newly DCBT program for Chinese adolescents with depressive symptoms.
Interventions
- Other: Digital cognitive behavioral therapy(DCBT) — Moca is a mobile application designed to deliver structural CBT for adolescents with mood problems. Moca provides six-twelve guided sessions with an estimated proceeding duration of 25-45min each, developed to be processed weekly. The content of each session includes the introduction of the core concepts and principles of CBT, psychological counseling dialogue, skill exercises, and homework. Content presentation forms include text, animation, audio, comics, etc. At the end of each module, the participants will be asked to submit homework that will ask them to apply their learned skills to nursing or daily life situations that they personally perceive as stressful. Participants can review the completed sessions and record their mood status during the intervention period.
- Other: Regular mental health curriculum — The content of regular mental health curriculum includes mental health education lecture. Few lectures address the knowledge and skills involved in CBT in such education lecture.
Primary outcomes
- Change in CDRS-R (Children's Depression Rating Scale) scores from baseline (Baseline of intervention period, 6 weeks, and 3 months follow-up (18 weeks))
Eligibility information
Inclusion Criteria:
1. Age 12 to 18 years;
2. Scored 28 or higher on the children's depression rating scale-revised (CDRS-R);
3. Have the ability to read and write in Chinese;
4. Participant and at least one of their guardians provided written consent;
5. Have access to mobile phone and internet.
Exclusion Criteria:
1. The researchers assessed that the adolescent's depressive symptoms were too severe to participate to CADS-D;
2. Scored 5 or higher on item 13 (suicidal ideation) on CDRS-R;
3. Participants who met diagnosis of other mental disorder except depression;
4. Severe physical illnesses or other physical disabilities that prevented the use of DCBT;
5. Within the past three months or currently undergoing any antidepressant treatment, including medication therapy, psychotherapy, and physical therapy;
6. Unavailability to follow up months after intervention.
Study locations
- The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-14.